Effects of hemodialysis on serum lipids and phospholipids of end-stage renal failure patients

Molecular and Cellular Biochemistry

Volumn 265, Issue 1-2, 2004, Pages 57-61

  Piperi, C ^a   Kalofoutis, C ^a   Tzivras, M ^a   Troupis, T ^a   Skenderis, A ^a   Kalofoutis, A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cholesterol; End stage renal failure; HDL; Hemodialysis; Serum phospholipids

Indexed keywords

CARDIOLIPIN; CHOLESTEROL; LIPID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLINOSITOL; PHOSPHOLIPID; SPHINGOMYELIN; TRIACYLGLYCEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHOSPHOLIPID BLOOD LEVEL; PROTEIN ANALYSIS; PROTEIN SECRETION; PROTEIN SYNTHESIS; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CELL MEMBRANE; CHEMISTRY; CHRONIC KIDNEY FAILURE; LIPID METABOLISM; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; AGED; CELL MEMBRANE; CHOLESTEROL, HDL; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPID METABOLISM; LIPIDS; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLINOSITOLS; PHOSPHOLIPIDS; RENAL DIALYSIS; TRIGLYCERIDES;

EID: 16644388459     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000044315.74038.78     Document Type: Article

References (31)

1. Attman PO, Samuelsson O, Alaupovic P: Lipoprotein metabolism in renal failure. Am J Kidney Dis 21: 573-592, 1993
2. Kasiske B: Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis 32: S142-S156, 1998
3. Levey A, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PW, Wright JT Jr: Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis 32: 853-906, 1998
4. Wanner C: Importance of hyperlipidaemia and therapy in renal patients. Nephrol Dial Transplant 15: S92-S96, 2000
5. Wheeler DC, Bernard DB: Lipid abnormalities in the nephritic syndrome: Causes, consequences and treatment. Am J Kidney Dis 23: 331-346, 1994
6. Shoji T, Nishizawa Y, Kawagishi T, Tanaka M, Kawasaki K, Tabata T, Inque T, Morii H: Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis. Atherosclerosis 131: 229-236, 1997
7. Oi K, Hirano T, Sakai S, Kawaguchi Y, Hosaya T: Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients. Kidney Int 56: S227-S228, 1999
8. Gillett MPT, Teixeira V, Dimenstein R: Decreased plasma lecithin: Cholesterol acyltransfer and associated changes in plasma and red cell lipids in uraemia. Nephrol Dial Transplant 8: 407-411, 1993
9. Gillett MPT, Obineche EN, El-Rokhaimi M, Lakhani MS, Abdulle A, Sulaiman M: Lecithin: Cholesterol acyltransfer, dyslipoproteinemia and membrane lipids in uraemia. J Nephrol 14: 472-480, 2001
10. Ordonez JD, Haitt RA, Killbrew EJ, Firman BH: The increased risk of coronary heart disease associated with nephritic syndrome. Kidney Int 44: 638-642, 1993
11. Chan MK, Varghese Z, Morrhead JF: Lipid abnormalities in uraemia, dialysis and transplantation. Kidney Int 44: 638-642, 1981
12. Kšniger M, Quaschning T, Wanner C, Schollmeyer P, KrŠmer-Guth A: Abnormalities in lipoprotein metabolism in hemodialysis patients. Kidney Int 56: S248-S250, 1999
13. Tutor JC, Par JM, Areses J, Garcia F: Detrmination of high-density lipoprotein phospholipids and its possible clinical application in the assessment of cardiovascular disease risk. Biometrica VI2: 65, 1981
14. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC: Enzymatic determination of total serum cholesterol. Clin Chem 20: 470-475, 1974
15. Wahalefed AW: Triglyceride determination after enzymatic hydrolysis. In: HU Bermeyer (ed). Methods of Enzymatic Analysis, Vol 4, Academic Press, New York, 1974, pp 1831-1835
16. Lopez-Virella HF, Stone P, Ellis J, Coltwell LA: Cholesterol determination in the HDL separated by precipitation with polyanions. J Lipid Res 11:583-595, 1970
17. Friedwald WT, Levy RI, Fredrikson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentifugation. Clin Chem 18: 499-502, 1972
18. Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA: Separation and quantitation of subclasses of human plasma high-density lipoproteins by a simple precipitation procedure. J Lipid Res 23: 1206-1223, 1982
19. Folch J, Lees M and Sloane-Stanley HG: A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-509, 1957
20. Kalofoutis A, Jullien J, Miras A: Influence of long-term exercise and training on heart and liver phospholipids in rats. Int J Biochem 5: 767-711, 1974
21. Kwiterovich RO, Sloan MR, Fredrikson MS: Glycolipids and other lipid constituents of normal human liver. J Lipid Res II: 322-330, 1970
22. Bartlett GR: Phosphorus assay in column chromatography. J Biol Chem 234: 466-468, 1959
23. Cano N, Coeyerehourq LC, Lacombe P: Perdialytic parenteral nutrition with lipids and amino acids to malnourished hemodialysis patients. Am J Clin Nutr 52: 726-730, 1990
24. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H: Impaired high-density lipoprotein metabolism in uremic patients. Kideny Int 41: 1653-1661, 1992
25. Dieplinger H, Schoenfeld PY, Fielding CJ: Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis. J Clin Invest 77: 1071-1083, 1986
26. Fleisher S, Bock HG, Gazzoti P. In: A. Klingerberg, G.F. Azzont (eds). Membrane Proteins in Transport and Phosphorylation, North Holland, Amsterdam, 1974, pp 125
27. 2+)-ATPase of the erythrocyte membrane. Reconstitution and effect of calmodulin and phospholipids. J Biol Chem 256: 395-401, 1981
28. Koval M, Pagano RE: Intracellular transport and metabolism of sphingomyelin. Biochim Biophys Acta 1082: 113-125, 1991
29. Jones LM, Michell RH: The relationship of calcium to receptor-controlled stimulation of phosphatidylinositol turnover. Effects of acetylcholine, adrenaline, calcium ions, cinchocaine and a bivalent cation ionophore on rat parotid-gland fragments. Biochem J 148: 479-185, 1975
30. +-stimulated adenosine triphosphatase system of brain microsomes. Arch Biochem Biophys 154: 56-67, 1973
31. Das ML, Haak ED, Crane FL: Proteolipids. IV. Formation of complexes between cytochrome c and purified phospholipids. Biochemistry 41: 859-865, 1965